US Medicare Rx plans "could harm seniors"

7 February 2001

Plans to provide US seniors with prescription drug coverage underMedicare could be harmful to their health, even leading them to be "medicated to death," according to a new alert for patients issued by the Association of American Physicians and Surgeons, which represents doctors in private practice.

"If seniors and doctors give in to the siren song of unlimited government-mandated free drugs, the safety of all seniors could be seriously compromised," write the alert's authors, Michael Glueck and Robert Cihak.

With seniors averaging more than a dozen prescriptions every year, innumerable complications and interactions are possible, according to the alert. A patient who is taking 10 medications will have the potential for millions of drug interactions, and no physician can completely understand all the interactions possible when multiple drug treatments are used. If Medicare were to be extended to cover all prescriptions, then so could the complications, it warns.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight